Drawing for PHENOME

USPTO serial 97722291

PHENOME

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BROWNING, KATHRYN ELISABETH
Law office
TMO LAW OFFICE 124 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PHENOME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karineh Khachatourian

KARINEH KHACHATOURIAN KXT LAW, LLP1775 WOODSIDE RD., SUITE 204REDWOOD CITY, CA 94061UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and reagents, namely, kits comprised of chemicals and reagents for performing assays following scientific protocols on microfluidic chips and characterization and stimulation of biological and immunological cells, for use in scientific research in the fields of biotechnology, pharmaceuticals, and cellular biology; chemicals and reagents, namely, kits comprised of chemicals and reagents for performing assays following scientific protocols on microfluidic chips, for use in scientific research in the fields of biotechnology, pharmaceuticals, and cellular biology; chemicals and reagents, namely, kits comprised of chemicals and reagents, for detection of proteins, including proteins produced by biological and immunological cells, for use in scientific research in the fields of biotechnology, pharmaceuticals, and cellular biology; chemicals and reagents, namely, kits comprised of chemicals and reagents, for preparation of nucleic acids for sequencing, for use in scientific research in the fields of biotechnology, pharmaceuticals, and cellular biologyACTIVE—
009Laboratory, scientific, optical and electrical apparatus and instruments, namely, microfluidics platforms comprised of cell visualization and processing hardware and recorded software for use with microfluidic chips for analysis, selection and manipulation of biological cells, biological material, and/or chemicals such as metabolites; Laboratory, scientific, optical and electrical apparatus and instruments, namely, microfluidics platforms comprised of cell visualization and processing hardware and recorded software for biological, genetic, medical and scientific research and analysis, and pharmaceutical development; microscopes for use with microfluidic chipsACTIVE—
010Medical apparatus, namely, medical instruments in the form of microscopes and microscope platforms that utilize microfluidic chips, for use in medical analysis and diagnosis of biological cells, biological material, and biological fluids; Medical apparatus, namely, medical instruments in the form of microscopes and microscope platforms that utilize microfluidic chips, for detection and use in medical analysis and diagnosis of biological cells, biological material, and biological fluidsACTIVE—
042Scientific, laboratory, research and development services, namely, performing assays following protocols on microfluidic chips for others, for research purposes in the fields of biotechnology, pharmaceuticals, and cell biology; providing scientific research and analysis services, namely, performing assays following protocols on microfluidic chips, for research purposes in the fields of biotechnology, pharmaceuticals, and cell biology; providing scientific research and development services, namely, performing assays following scientific protocols for others, for preparation of nucleic acids for sequencing; providing scientific research and development services, namely, performing scientific protocols in the nature of assays and scientific analysis for others, for preparation of nucleic acids for sequencing; providing scientific research and development services, namely, performing assays following scientific protocols on microfluidic chips for others, for selecting biological cells having desirable properties; providing scientific research and development services, namely, performing assays and protocols on microfluidic chips on behalf of others, for selecting biological cells having desirable properties; providing technical support and field services in the nature of troubleshooting of computer software problems for others using recorded software sold as a component part of laboratory, scientific, optical and electrical apparatus and instruments for use with microfluidic and optofluidic chips for scientific, laboratory, research and development in the fields of biotechnology, pharmaceuticals, and cell biology, namely, analysis, selection and manipulation of biological cells, biological material, and chemicals such as metabolites, and for biological, genetic, chemical, medical and scientific research and analysis; providing others temporary use of non-downloadable cloud based software for use with laboratory, scientific, optical and electrical apparatus and instruments for use with microfluidic and optofluidic chips for biological, genetic, medical and scientific research and analysis, and pharmaceutical developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 30, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 30, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 30, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 16, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2023LOPELETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN—
Oct 4, 2023DOCKASSIGNED TO EXAMINER—
Sep 20, 2023DOCKASSIGNED TO EXAMINER—
Mar 25, 2023LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Jan 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance